TABLE 3.
Factors Associated With the Timeline of Care Among Patients With Breast Pathology, North Carolina Breast and Cervical Cancer Control Program, 2008–2018
| Time to Diagnosis, IRR (95% CI) | P | Time to Treatment, IRR (95% CI) | P | Time From Imaging to Treatment, IRR (95% CI) | P | Time From Diagnosis to Treatment, IRR (95% CI) | P | |
|---|---|---|---|---|---|---|---|---|
| Age (y) | 1.01 (1.01–1.02) | <.001 | 1.01 (1.01–1.01) | <.001 | 1.01 (1–1.01) | <.001 | 1.01 (1–1.02) | .08 |
| Race/ethnicity | ||||||||
| Non-Hispanic White | Reference | .02 | Reference | .001 | Reference | .006 | Reference | .03 |
| Asian/Pacific Islander | 1.09 (0.72–1.64) | .69 | 1.05 (0.73–1.50) | .80 | 1.28 (0.87–1.88) | .20 | 0.91 (0.48–1.74) | .78 |
| Hispanic | 1.16 (0.98–1.37) | .08 | 1.22 (1.05–1.41) | .01 | 1.14 (0.98–1.33) | .10 | 1.27 (0.97–1.66) | .08 |
| American Indian | 0.73 (0.48–1.10) | .13 | 1.02 (0.71–1.46) | .92 | 1.12 (0.76–1.64) | .56 | 1.61 (0.85–3.06) | .14 |
| Non-Hispanic Black | 1.17 (1.06–1.29) | .002 | 1.20 (1.10–1.31) | <.001 | 1.2 (1.09–1.31) | <.001 | 1.27 (1.09–1.48) | .002 |
| Unknown | 0.99 (0.58–1.69) | .98 | 1.04 (0.65–1.66) | .86 | 1.09 (0.66–1.78) | .74 | 1.11 (0.48–2.54) | .81 |
| Program year | 0.96 (0.95–0.98) | <.001 | 0.97 (0.95–0.98) | <.001 | 0.97 (0.95–0.98) | <.001 | 0.97 (0.95–0.99) | .01 |
| Funding | <.001 | <.001 | <.001 | .13 | ||||
| Not funded | Reference | Reference | Reference | Reference | ||||
| Partially funded | 1.55 (1.33–1.8) | <.001 | 1.44 (1.26–1.65) | <.001 | 1.41 (1.22–1.62) | <.001 | 1.29 (1.01–1.64) | .04 |
| Fully funded | 1.75 (1.52–2.02) | <.001 | 1.52 (1.34–1.73) | <.001 | 1.31 (1.15–1.49) | <.001 | 1.21 (0.97–1.52) | .09 |
| Pathologic diagnosis | .50 | .93 | .77 | .78 | ||||
| Atypia | Reference | Reference | Reference | Reference | ||||
| Malignancy | 1.07 (0.88–1.31) | .50 | 1.01 (0.84–1.21) | .93 | 0.97 (0.8–1.18) | .77 | 0.95 (0.69–1.32) | .78 |
Abbreviations: CI, confidence interval; IRR, incidence rate ratio.